Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Implant,Ti,4.3X13: medical device reports filed with FDA

3,414 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

3,414
device reports naming the brand
0% of all MAUDE reports · about 488 a year
1,243
reports, 12 months to August 2026
791 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 3,414 reports that name the brand "GM Helix Implant,Ti,4.3X13" (endosseous dental implant), received between July 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

1,243 reports arrived in the 12 months to August 2026, up 57% from 791 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (77.8%), loss of osseointegration (13.1%) and difficult to insert (1.5%). The patient problems coded most often are pain, fibrosis and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

086172Sep 2021: 14Oct 2021: 18Nov 2021: 8Dec 2021: 72022Jan 2022: 29Feb 2022: 9Mar 2022: 22Apr 2022: 24May 2022: 19Jun 2022: 19Jul 2022: 22Aug 2022: 47Sep 2022: 31Oct 2022: 49Nov 2022: 25Dec 2022: 292023Jan 2023: 38Feb 2023: 25Mar 2023: 49Apr 2023: 31May 2023: 36Jun 2023: 54Jul 2023: 15Aug 2023: 36Sep 2023: 22Oct 2023: 47Nov 2023: 57Dec 2023: 262024Jan 2024: 38Feb 2024: 26Mar 2024: 30Apr 2024: 71May 2024: 64Jun 2024: 65Jul 2024: 77Aug 2024: 56Sep 2024: 60Oct 2024: 89Nov 2024: 76Dec 2024: 612025Jan 2025: 60Feb 2025: 50Mar 2025: 53Apr 2025: 27May 2025: 0Jun 2025: 168Jul 2025: 72Aug 2025: 75Sep 2025: 71Oct 2025: 96Nov 2025: 77Dec 2025: 1722026Jan 2026: 74Feb 2026: 99Mar 2026: 95Apr 2026: 110May 2026: 106Jun 2026: 129Jul 2026: 129Aug 2026: 85

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04619212019: 1220192020: 5820202021: 12220212022: 32520222023: 43620232024: 71320242025: 92120252026: 8272026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%3,414
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report83%2,833
Voluntary report0%0
User facility report0%0
Distributor report17%581
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,65677.8%62.8%
Loss of osseointegration44813.1%22.4%
Difficult to insertthe device was hard to insert521.5%0.4%
Fracturea broken bone100.3%1.6%
Separation failure100.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified83824.5%
Fibrosis78022.8%
Hemorrhage/blood loss/bleeding2407%
Inflammationinflammation2356.9%
Swelling/ edema1975.8%
Fistula1043%
Abscessa collection of pus962.8%
Hyperresponsive to stimuli792.3%
Tissue damage200.6%
Hypersensitivity/allergic reaction160.5%
Numbnessnumbness160.5%
Sinus perforation120.4%
Swellingswelling40.1%
Failure of implant30.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Implant,Ti,4.3X13Product code DZEAll MAUDE reports
Reports3,4143,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer83%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Implant,Ti,4.3X13 reports

How many FDA reports name GM Helix Implant,Ti,4.3X13?

3,414 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,243 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (77.8%), loss of osseointegration (13.1%), difficult to insert (1.5%), fracture (0.3%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (83%) and distributor reports (17%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Implant,Ti,4.3X13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.